Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AdvaMed’s MedTech ’21: Focus On MCIT, MDUFA At Hybrid Meeting

Executive Summary

Virtual and in-person events are planned for Washington, DC, and Minneapolis, MN, during the trade group gathering.

You may also be interested in...



Prioritize Medtech In Addressing Semiconductor Shortage, AdvaMed Says

The device trade group told the US Department of Commerce that policies put in place to address the ongoing supply chain issue should prioritize the unique role of medical technology.

CMS Dashes Industry Hopes For MCIT Rule Any Time Soon

The US Medicare agency has proposed to withdraw a rule that would give temporary automatic coverage to breakthrough devices, stating the rule doesn’t meet its evidence threshold and could put patients at risk.­­­­­­­

Biden Turns To Cold War Measure To Expand Access to COVID-19 Tests

President Biden outlined his pandemic strategy in a speech from the White House Thursday. The president invoked the Defense Production Act to quicken the availability of tests and issued a series of steps to increase vaccinations, including mandates.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

MT144504

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel